These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination. Zheng C; Kar I; Chen CK; Sau C; Woodson S; Serra A; Abboud H CNS Drugs; 2020 Sep; 34(9):879-896. PubMed ID: 32780300 [TBL] [Abstract][Full Text] [Related]
6. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial. Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A; Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496 [TBL] [Abstract][Full Text] [Related]
8. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration. Chen R; Lan Z; Ye J; Pang L; Liu Y; Wu W; Qin X; Guo Y; Zhang P Front Immunol; 2021; 12():589095. PubMed ID: 33995341 [TBL] [Abstract][Full Text] [Related]
9. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review. Quirch M; Lee J; Rehman S J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537 [TBL] [Abstract][Full Text] [Related]
10. Antibody response after COVID-19 vaccination in intravenous immunoglobulin-treated immune neuropathies. Svačina MKR; Meißner A; Schweitzer F; Ladwig A; Sprenger-Svačina A; Klein I; Wüstenberg H; Kohle F; Schneider C; Grether NB; Wunderlich G; Fink GR; Klein F; Di Cristanziano V; Lehmann HC Eur J Neurol; 2022 Nov; 29(11):3380-3388. PubMed ID: 35842740 [TBL] [Abstract][Full Text] [Related]
11. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem. Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359 [TBL] [Abstract][Full Text] [Related]
12. Before the "cytokine storm": Boosting efferocytosis as an effective strategy against SARS-CoV-2 infection and associated complications. Dutta S; Mukherjee A; Nongthomba U Cytokine Growth Factor Rev; 2022 Feb; 63():108-118. PubMed ID: 35039221 [TBL] [Abstract][Full Text] [Related]
13. A review of monoclonal antibodies in COVID-19: Role in immunotherapy, vaccine development and viral detection. Tabll AA; Shahein YE; Omran MM; Elnakib MM; Ragheb AA; Amer KE Hum Antibodies; 2021; 29(3):179-191. PubMed ID: 33998533 [TBL] [Abstract][Full Text] [Related]
14. Pathogenesis-directed therapy of 2019 novel coronavirus disease. Stratton CW; Tang YW; Lu H J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355 [TBL] [Abstract][Full Text] [Related]
15. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants. Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303 [TBL] [Abstract][Full Text] [Related]
16. Immune evasion of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2); molecular approaches. Ahmadi S; Bazargan M; Elahi R; Esmaeilzadeh A Mol Immunol; 2023 Apr; 156():10-19. PubMed ID: 36857806 [TBL] [Abstract][Full Text] [Related]
17. Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management. Anka AU; Tahir MI; Abubakar SD; Alsabbagh M; Zian Z; Hamedifar H; Sabzevari A; Azizi G Scand J Immunol; 2021 Apr; 93(4):e12998. PubMed ID: 33190302 [TBL] [Abstract][Full Text] [Related]
18. Cytokines and COVID-19: friends or foes? Rokni M; Hamblin MR; Rezaei N Hum Vaccin Immunother; 2020 Oct; 16(10):2363-2365. PubMed ID: 32841579 [TBL] [Abstract][Full Text] [Related]
19. [Advances in the research of mechanism and related immunotherapy on the cytokine storm induced by coronavirus disease 2019]. Chen C; Zhang XR; Ju ZY; He WF Zhonghua Shao Shang Za Zhi; 2020 Jun; 36(6):471-475. PubMed ID: 32114747 [TBL] [Abstract][Full Text] [Related]
20. The Coronavirus Pandemic: What Does the Evidence Show? Paudel S; Dangal G; Chalise A; Bhandari TR; Dangal O J Nepal Health Res Counc; 2020 Apr; 18(1):1-9. PubMed ID: 32335585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]